Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser (Thr) monoclonal antibody (MLS 128)

H Nakada, Y Numata, M Inoue, N Tanaka… - Journal of Biological …, 1991 - Elsevier
H Nakada, Y Numata, M Inoue, N Tanaka, H Kitagawa, I Funakoshi, S Fukui, I Yamashina
Journal of Biological Chemistry, 1991Elsevier
To determine the epitopic structure for an anti-GalNAc alpha-Ser (Thr)(anti-Tn) monoclonal
antibody, MLS 128, asialo-ovine submaxillary mucin was digested with various proteases,
and the digests were fractionated by immunoaffinity column chromatography and high
performance liquid chromatography. From the tryptic digest, a glycopeptide, GP-I, and five
other glycopeptides, GP-1-5, were obtained as bound and unbound fractions, respectively,
of the immunoaffinity column. By solid phase radioimmunoassaying, it was found that GP-I …
To determine the epitopic structure for an anti-GalNAc alpha-Ser(Thr) (anti-Tn) monoclonal antibody, MLS 128, asialo-ovine submaxillary mucin was digested with various proteases, and the digests were fractionated by immunoaffinity column chromatography and high performance liquid chromatography. From the tryptic digest, a glycopeptide, GP-I, and five other glycopeptides, GP-1-5, were obtained as bound and unbound fractions, respectively, of the immunoaffinity column. By solid phase radioimmunoassaying, it was found that GP-I was strongly immunoreactive, whereas GP-1-5 were poorly immunoreactive. On treatment with V8 protease, GP-I was converted to two glycopeptides, one with poor reactivity and the other with intermediate reactivity. From the thermolysin digest, the smallest fragment, GP-II, was isolated, which was as strongly immunoreactive as GP-I. GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached. Other anti-Tn monoclonal antibodies, NCC-LU-35 and CA 3239, showed essentially the same reactivity to these glycopeptides as MLS 128 did. The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr. These results indicate that a glycopeptide including a cluster structure, Ser*-Thr*-Thr*, is an essential part of the epitope recognized by anti-Tn antibodies.
Elsevier